NEW YORK--(BUSINESS WIRE)-- The U.S. Food and Drug Administration (FDA) today opened a public comment period on Philip Morris International’s (PMI--NYSE: PM) application seeking authorization to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback